Skip to main content
Log in

Update on Transcatheter Device Closure of Congenital Septal Defects

  • Congenital Heart Disease (RA Krasuski and G Fleming, Section Editors)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript


Purpose of Review

The goal of this paper is to review currently available devices for closure of atrial septal defects (ASDs) and ventricular septal defects (VSDs).

Recent Findings

Favorable results from the ASSURED trial resulted in FDA approval for the most recently developed device for transcatheter ASD closure in the United States. Further studies are required to assist in the development or approval of safe devices for transcatheter perimembranous VSD closure in pediatric patients.


Device closure is the less invasive and preferred management option for many ASDs, with multiple studies demonstrating lower complication rates, shorter hospital stays, and lower mortality than surgical repair. Complex ASDs that make device closure more difficult include large defects, rim deficiencies, fenestrated defects, multiple defects, and the presence of pulmonary arterial hypertension. Device closure has also become an accepted alternative to surgery for some types of ventricular septal defects VSDs, though challenges and limitations remain. Future innovations including novel devices and techniques are needed to further expand on the types of defects that can be safely closed via transcatheter approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

© 2023. All rights reserved)

Fig. 3

(© 2017 W. L. Gore & Associates, Inc. Used with permission)

Fig. 4

© 2023. All rights reserved)

Fig. 5

Similar content being viewed by others

Data Availability

No personal data associated with this manuscipt.  All data are publically available through prior publications.


Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Liu Y, Chen S, Zühlke L, Black GC, Choy MK, Li N, Keavney BD. Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies. Int J Epidemiol. 2019;48(2):455–63. PMID: 30783674; PMCID: PMC6469300.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Webb G, Gatzoulis MA. Atrial septal defects in the adult: recent progress and overview. Circulation. 2006;114(15):1645–53. PMID: 17030704.

    Article  PubMed  Google Scholar 

  3. Mills NL, King TD. Nonoperative closure of left-to-right shunts. J Thorac Cardiovasc Surg. 1976;72(3):371–8. PMID: 134183.

    Article  CAS  PubMed  Google Scholar 

  4. Villablanca PA, Briston DA, Rodés-Cabau J, Briceno DF, Rao G, Aljoudi M, et al. Treatment options for the closure of secundum atrial septal defects: A systematic review and meta-analysis. Int J Cardiol. 2017;15(241):149–55. Epub 2017 Mar 24 PMID: 28390741.

    Article  Google Scholar 

  5. Turner DR, Owada CY, Sang CJ Jr, Khan M, Lim DS. Closure of Secundum Atrial Septal Defects With the AMPLATZER Septal Occluder: A Prospective, Multicenter, Post-Approval Study. Circ Cardiovasc Interv. 2017;10(8):e004212. PMID: 28801537; PMCID: PMC5559192.

  6. Chambault AL, Olsen K, Brown LJ, Mellor SL, Sorathia N, Thomas AE, et al. Transcatheter versus surgical closure of atrial septal defects: a systematic review and meta-analysis of clinical outcomes. Cardiol Young. 2022;32(1):1–9. Epub 2021 Nov 25 PMID: 34819196.

    Article  PubMed  Google Scholar 

  7. McElhinney DB, Quartermain MD, Kenny D, Alboliras E, Amin Z. Relative Risk Factors for Cardiac Erosion Following Transcatheter Closure of Atrial Septal Defects: A Case-Control Study. Circulation. 2016;133(18):1738–46. Epub 2016 Mar 21 PMID: 27002094.

    Article  PubMed  Google Scholar 

  8. DiBardino DJ, McElhinney DB, Kaza AK, Mayer JE Jr. Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database. J Thorac Cardiovasc Surg. 2009;137:1334–41.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv. 2004;63(4):496–502. PMID: 15558755.

    Article  PubMed  Google Scholar 

  10. Pradhan P, Jain S, Sen S, Dalvi B. Use of cribriform amplatzer septal occluder in the pediatric population: Feasibility, safety, and technical considerations. Ann Pediatr Cardiol. 2021;14(2):159–164. Epub 2021 Apr 10. PMID: 34103854; PMCID: PMC8174635.

  11. Awad SM, Garay FF, Cao QL, Hijazi ZM. Multiple Amplatzer septal occluder devices for multiple atrial communications: immediate and long-term follow-up results. Catheter Cardiovasc Interv. 2007;70(2):265–73. PMID: 17630666.

    Article  PubMed  Google Scholar 

  12. Gillespie MJ, Javois AJ, Moore P, Forbes T, Paolillo JA; GSO Investigator Group. Use of the GORE® CARDIOFORM Septal Occluder for percutaneous closure of secundum atrial septal defects: Results of the multicenter U.S. IDE trial. Catheter Cardiovasc Interv. 2020;95(7):1296–1304. Epub 2020 Feb 28. PMID: 32108423.

  13. Kubicki R, Fingerhut K, Uhl M, Hummel J, Höhn R, Reineker K, et al. Wire-frame integrity of patch-like Gore devices following atrial septal defect closure. Catheter Cardiovasc Interv. 2019;93(4):E238–43. Epub 2019 Jan 24 PMID: 30680882.

    Article  CAS  PubMed  Google Scholar 

  14. • Sommer RJ, Love BA, Paolillo JA, Gray RG, Goldstein BH, Morgan GJ, et al. ASSURED clinical study: New GORE® CARDIOFORM ASD occluder for transcatheter closure of atrial septal defect. Catheter Cardiovasc Interv. 2020;95(7):1285–1295. Epub 2020 Jan 14. PMID: 31943749. Findings from this study demonstrated high implant success rates with closure of atrial septal defects resulting in FDA approval of the newest available transcatheter device in the United States.

  15. Wang JK, Chiu SN, Lin MT, Chen CA, Lu CW, Wu MH. Transcatheter Closure of Atrial Septal Defect Associated With Pulmonary Artery Hypertension using Fenestrated Devices. Am J Cardiol. 2021;15(147):122–8. Epub 2021 Mar 3 PMID: 33667439.

    Article  CAS  Google Scholar 

  16. Lehner A, Schulze-Neick I, Fischer M, Fernandez-Rodriguez S, Ulrich S, Haas NA, et al. The Creation of an Interatrial Right-To-Left Shunt in Patients with Severe, Irreversible Pulmonary Hypertension: Rationale, Devices, Outcomes. Curr Cardiol Rep. 2019;21(5):31. PMID: 30887235.

    Article  PubMed  Google Scholar 

  17. Eilers LF, Gowda ST, Gowda S, Lahiri S, Aggarwal V, Stapleton GE, et al. Mullins-Sheath Facilitated Delivery of Gore Cardioform ASD Occluder Devices for Closure of Large or Challenging Secundum Atrial Septal Defects. J Invasive Cardiol. 2021;33(6):E425–30 Epub 2021 Apr 23 PMID: 33893794.

    PubMed  Google Scholar 

  18. Eilers LF, Krasuski RA, Serfas JD, Downing TE, Sandoval JP, Ligon RA, et al. Suture assisted technique for Gore Cardioform ASD Occluder delivery sheath deflection to facilitate closure of large or complex secundum ASDs. Poster presented at: Pediatric and Congenital Interventional Cardiovascular Society Symposium; 2022; Chicago Il.

  19. Kannan BR, Francis E, Sivakumar K, Anil SR, Kumar RK. Transcatheter closure of very large (>or= 25 mm) atrial septal defects using the Amplatzer septal occluder. Catheter Cardiovasc Interv. 2003;59(4):522–7. PMID: 12891620.

    Article  PubMed  Google Scholar 

  20. Dalvi BV, Pinto RJ, Gupta A. New technique for device closure of large atrial septal defects. Catheter Cardiovasc Interv. 2005;64(1):102–7. PMID: 15619315.

    Article  PubMed  Google Scholar 

  21. Thanopoulos BD, Dardas P, Ninios V, Eleftherakis N, Karanasios E. Transcatheter closure of large atrial septal defects with deficient aortic or posterior rims using the “Greek maneuver.” A multicenter study Int J Cardiol. 2013;168(4):3643–6. Epub 2013 May 25 PMID: 23714593.

    Article  PubMed  Google Scholar 

  22. Quek SC, Wu WX, Chan KY, Ang P, Ho TF, Yip W. A novel “in-situ tulip-bud deployment” method for transcatheter closure of secundum atrial septal defect. J Invasive Cardiol. 2009;21(12):623–6. PMID: 19966363.

    PubMed  Google Scholar 

  23. Haddad RN, Khraiche D, Bonnet D, Meot M, Malekzadeh-Milani S. Preliminary Experience With the New Amplatzer™ Trevisio™ Delivery System in Transcatheter Atrial Septal Defect Closures in Children. Front Pediatr. 2021 Mar 11;9:641742. PMID: 33791259; PMCID: PMC8006412.

  24. Hansen JH, Duong P, Jivanji SGM, Jones M, Kabir S, Butera G, et al. Transcatheter Correction of Superior Sinus Venosus Atrial Septal Defects as an Alternative to Surgical Treatment. J Am Coll Cardiol. 2020;75(11):1266–78. PMID: 32192652.

    Article  PubMed  Google Scholar 

  25. Torres A, Gersony WM, Hellenbrand W. Closure of unroofed coronary sinus with a covered stent in a symptomatic infant. Catheter Cardiovasc Interv. 2007;70(5):745–8. PMID: 17563096.

    Article  PubMed  Google Scholar 

  26. Kijima Y, Taniguchi M, Akagi T. Catheter closure of coronary sinus atrial septal defect using Amplatzer Septal Occluder. Cardiol Young. 2012;22(2):223–6. Epub 2011 Jul 26 PMID: 21787458.

    Article  PubMed  Google Scholar 

  27. Hoffman JI. Incidence of congenital heart disease: I—postnatal incidence. Pediatr Cardiol. 1995;16:103–13.

    Article  CAS  PubMed  Google Scholar 

  28. Roguin N, Du ZD, Barak M, Nasser N, Hershkowitz S, Milgram E. High prevalence of muscular ventricular septal defect in neonates. J Am Coll Cardiol. 1995;26:1545–8.

    Article  CAS  PubMed  Google Scholar 

  29. Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890–900.

    Article  PubMed  Google Scholar 

  30. Lopez L, Houyel L, Colan SD, et al. Classification of ventricular septal defects for the eleventh iteration of the international classification of diseases—striving for consensus: a report from the International Society for Nomenclature of Paediatric and Congenital Heart Disease. Ann Thorac Surg. 2018;106:1578–89.

    Article  PubMed  Google Scholar 

  31. Morray BH. Ventricular Septal Defect Closure Devices, Techniques, and Outcomes. Interv Cardiol Clin. 2019;8(1):1–10. Epub 2018 Oct 26 PMID: 30449417.

    Article  PubMed  Google Scholar 

  32. Stout KK, Daniels CJ, Aboulhosn JA, et al. AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018.

  33. Lock JE, Block PC, McKay RG, Baim DS, Keane JF. Transcatheter closure of ventricular septal defects. Circulation. 1988;78(2):361–8. PMID: 3396173.

    Article  CAS  PubMed  Google Scholar 

  34. Rigby ML, Redington AN. Primary transcatheter umbrella closure of perimembranous ventricular septal defect. Br Heart J. 1994;72(4):368–71. PMID: 7833197; PMCID: PMC1025549.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Kalra GS, Verma PK, Dhall A, Singh S, Arora R. Transcatheter device closure of ventricular septal defects: immediate results and intermediate-term follow-up. Am Heart J. 1999;138(2 Pt 1):339–44. PMID: 10426849.

    Article  CAS  PubMed  Google Scholar 

  36. Fu YC, Bass J, Amin Z, Radtke W, Cheatham JP, Hellenbrand WE, et al. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial. J Am Coll Cardiol. 2006;47(2):319–25. PMID: 16412854.

  37. Butera G, Carminati M, Chessa M, et al. Transcatheter closure of perimembranous ventricular septal defects: early and long-term results. J Am Coll Cardiol. 2007;28(19):2361–8.

    Google Scholar 

  38. Predescu D, Chaturvei RR, Friedberg MK, et al. Complete heart block associated with device closure of perimembranous ventricular septal defects. J Thorac Cardiovasc Surg. 2008;136(5):1223–1228.

  39. Penny DJ, Vick GW 3rd. Ventricular septal defect. Lancet. 2011;377(9771):1103–12. Epub 2011 Feb 23 PMID: 21349577.

    Article  PubMed  Google Scholar 

  40. Feltes TF, Bacha E, Beekman RH III, Cheatham JP, Feinstein JA, Gomes AS, et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation. 2011;123(22):2607–52. Epub 2011 May 2. PMID: 21536996.

  41. Holzer R, Balzer D, Cao QL, Lock K, Hijazi ZM; Amplatzer Muscular Ventricular Septal Defect Investigators. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry. J Am Coll Cardiol. 2004;43(7):1257–63. PMID: 15063439.

  42. Hijazi ZM, Hakim F, Al-Fadley F, Abdelhamid J, Cao QL. Transcatheter closure of single muscular ventricular septal defects using the amplatzer muscular VSD occluder: initial results and technical considerations. Catheter Cardiovasc Interv. 2000;49(2):167–72.;2-s. PMID: 10642766.

    Article  CAS  PubMed  Google Scholar 

  43. Thanopoulos BD, Karanassios E, Tsaousis G, Papadopoulos GS, Stefanadis C. Catheter closure of congenital/acquired muscular VSDs and perimembranous VSDs using the Amplatzer devices. J Interv Cardiol. 2003;16(5):399–407. PMID: 14603798.

    Article  PubMed  Google Scholar 

  44. Carminati M, Butera G, Chessa M, Drago M, Negura D, Piazza L. Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders. Am J Cardiol. 2005;96(12A):52L-58L. Epub 2005 Nov 2 PMID: 16399093.

    Article  PubMed  Google Scholar 

  45. Jameel AA, Arfi AM, Arif H, Amjad K, Omar GM. Retrograde approach for device closure of muscular ventricular septal defects in children and adolescents, using the Amplatzer muscular ventricular septal defect occluder. Pediatr Cardiol. 2006;27(6):720–8. Epub 2006 Nov 7. PMID: 17091325.

  46. Wu L, Tanidir IC, Ye D, Zhang X, Li B, Zhu D, et al. Hybrid Transthoracic Periventricular Device Closure of Ventricular Septal Defects: Single- Center Experience. Braz J Cardiovasc Surg. 2021;36(1):48–56. PMID: 33118345; PMCID: PMC7918382.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Gray RG, Menon SC, Johnson JT, Armstrong AK, Bingler MA, Breinholt JP, et al. Acute and midterm results following perventricular device closure of muscular ventricular septal defects: A multicenter PICES investigation. Catheter Cardiovasc Interv. 2017;90(2):281–9. Epub 2017 May 8 PMID: 28805027.

    Article  PubMed  Google Scholar 

  48. Hong ZN, Chen Q, Huang LQ, Cao H. A meta-analysis of perventricular device closure of perimembranous ventricular septal defect. J Cardiothorac Surg. 2019;14(1):119. PMID: 31248430; PMCID: PMC6598304.

    Article  PubMed  PubMed Central  Google Scholar 

  49. El Said HG, Bratincsak A, Gordon BM, et al. Closure of perimembranous ventricular septal defects with aneurysmal tissue using the Amplazter Duct occluder 1: lessons learned and medium term follow up. Catheter Cardiovas Interv. 2012;80(6):895–903.

    Article  Google Scholar 

  50. Lee SM, Song JY, Choi JY, Lee SY, Paik JS, Chang SI, et al. Transcatheter closure of perimembranous ventricular septal defect using Amplatzer ductal occluder. Catheter Cardiovasc Interv. 2013;82(7):1141–6. Epub 2013 Aug 20 PMID: 23554093.

    Article  Google Scholar 

  51. El-Sisi A, Sobhy R, Jaccoub V, Hamza H. Perimembranous Ventricular Septal Defect Device Closure: Choosing Between Amplatzer Duct Occluder I and II. Pediatr Cardiol. 2017;38(3):596–602. Epub 2017 Mar 1 PMID: 28251252.

    Article  PubMed  Google Scholar 

  52. Koneti NR, Penumatsa RR, Kanchi V, Arramraj SK, Bhupathiraju S. Retrograde transcatheter closure of ventricular septal defects in children using the Amplatzer Duct Occluder II. Catheter Cardiovasc Interv. 2011;77(2):252–9. PMID: 20578168.

  53. Ghosh S, Sridhar A, Sivaprakasam M. Complete heart block following transcatheter closure of perimembranous VSD using amplatzer duct occluder II. Catheter Cardiovasc Interv. 2018;92(5):921–4. Epub 2017 Jul 14 PMID: 28707408.

    Article  PubMed  Google Scholar 

  54. • Liu S, Zhang W, Li J, Wang S, Qian M, Shi J, et al. Transcatheter Closure of Perimembranous and Intracristal Ventricular Septal Defects Using Amplatzer Duct Occluder II in Children. J Interv Cardiol. 2021;2021:4091888. PMID: 34621141; PMCID: PMC8452420. Findings from this study describe success and complication rates for transcatheter perimembranous VSD device closure in pediatric patients with one of the few devices available in the United States.

  55. Haas NA, Kock L, Bertram H, Boekenkamp R, De Wolf D, Ditkivskyy I, et al. Interventional VSD-Closure with the Nit-Occlud® Lê VSD-Coil in 110 Patients: Early and Midterm Results of the EUREVECO-Registry. Pediatr Cardiol. 2017;38(2):215–27. Epub 2016 Nov 15 PMID: 27847970.

    Article  PubMed  Google Scholar 

  56. Kozlik-Feldmann R, Lorber A, Sievert H, Ewert P, Jux C, Müller GC, et al. Long-term outcome of perimembranous VSD closure using the Nit-Occlud® Lê VSD coil system. Clin Res Cardiol. 2021;110(3):382–390. Epub 2020 Oct 31. PMID: 33128576; PMCID: PMC7906931.

  57. Esteves CA, Solarewicz LA, Cassar R, Neves JR, Esteves V, Arrieta R. Occlusion of the perimembranous ventricular septal defect using CERA® devices. Catheter Cardiovasc Interv. 2012;80(2):182–7. Epub 2012 May 4 PMID: 22431503.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Reid C. Chamberlain.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Congenital Heart Disease

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wood, K.P., Fleming, G.A. & Chamberlain, R.C. Update on Transcatheter Device Closure of Congenital Septal Defects. Curr Cardiol Rep 25, 1083–1093 (2023).

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: